Estriol Vaginal Cream

Estriol (E3) is a weak estrogen, but highly effective locally inside the vagina.

Local mechanisms (primary)

• Binds to estrogen receptors (ER-α and ER-β) in vaginal epithelium.
• Increases cell proliferation → thicker, more elastic epithelium.
• Restores vaginal pH (acidic) by increasing glycogen → supports Lactobacillus.
• Improves lubrication, reduces dryness and micro-tears.
• Increases local blood flow.
• Strengthens urethral mucosa, helping reduce recurrent UTIs.

Systemic

• Very minimal systemic absorption compared to estradiol.
• Very low endometrial stimulation at low maintenance doses.

Standard dosing

Initial (loading):

• 5 mg – 1 mg estriol vaginal cream, once daily for 2–3 weeks.

Maintenance:

• 2–3 times per week (most common = twice weekly, e.g., Mon–Thu).

Application

• Apply at bedtime for better retention.
• Insert into lower third of vagina.
• Optionally a small amount may be applied externally for vulvar dryness.

Adjustment

• Severe atrophy → daily for 3–4 weeks then taper.
• Maintenance long-term is safe due to minimal systemic effect.

• Genitourinary syndrome of menopause (GSM)
• Vaginal dryness
• Dyspareunia (pain with intercourse)
• Vulvovaginal atrophy
• Postmenopausal itching/burning
• Recurrent UTIs due to atrophy
• Post-partum low estrogen (off-label in some regions)

Avoid or use only with specialist supervision in:

• History of estrogen-dependent malignancy (e.g., breast cancer)
• Undiagnosed vaginal or uterine bleeding
• Active or history of DVT/PE
• Severe liver dysfunction
• Known or suspected pregnancy
• Hypersensitivity to estriol or excipients

Note: Some breast cancer patients may still use low-dose vaginal estrogen under oncologist approval.

Local (most common)

• Mild irritation/burning
• Itching
• Increased vaginal discharge
• Light spotting
• Vulvar sensitivity

Systemic (rare due to low absorption)

• Breast tenderness
• Headache
• Mild nausea
• Fluid retention
• Mood changes (rare)

Estriol vaginal cream has very low interaction risk, but possible considerations:

May need caution

• Aromatase inhibitors (AI)
  • Small systemic rise in estrogen possible → check with oncologist.
• Warfarin
  • Theoretical changes in clotting if high doses used; monitor INR.
• Vaginal antifungals, lubricants, oils
  • May reduce absorption → apply estriol at a different time (prefer bedtime).

Generally safe with

• Most systemic medications
• Antibiotics
• Antihypertensives
• Thyroid medication
• SSRIs/SNRIs
• Supplements

Key references used in clinical practice:

1. North American Menopause Society (NAMS) 2020 & 2023 Position Statements – Hormone therapy & vaginal estrogen guidelines.
2. EMAS (European Menopause and Andropause Society) Clinical Guidelines – Local estrogen therapy for GSM.
3. “Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.” Menopause, 2020.
4. Eriksen PS et al. “A comparative study of estriol and estradiol vaginal cream.” Acta Obstet Gynecol Scand.
5. Santen RJ. “Systemic absorption of vaginally administered estrogen.” J Clin Endocrinol Metab.
6. Palma F. “Estriol vaginal cream efficacy and safety.”
7. ISSWSH Clinical Practice Guidelines for GSM (2020).
8. ACOG Practice Bulletin – Treatment of urogenital symptoms with vaginal estrogen.

Estriol vaginal cream is a form of hormone replacement therapy used to treat vaginal dryness, burning, and itching, and other symptoms associated with menopause, such as pain during intercourse. It is a topical estrogen that works by restoring vaginal tissue